Definition and clinical significance of tumour rupture in gastrointestinal stromal tumours of the small intestine

Percutaneous Core Needle Biopsy in Retroperitoneal Sarcomas Does Not Influence Local Recurrence or Overall Survival

(2014) M. J. Wilkinson et al.   ANNALS OF SURGICAL ONCOLOGY

Risk factors for gastrointestinal stromal tumor recurrence in patients treated with adjuvant imatinib

(2014) Heikki Joensuu et al.   CANCER

Re-appraisal of risk classifications for primary gastrointestinal stromal tumors (GISTs) after complete resection: indications for adjuvant therapy

(2014) Yoshitomo Yanagimoto et al.   Gastric Cancer

One vs Three Years of Adjuvant Imatinib for Operable Gastrointestinal Stromal Tumor

(2012) Heikki Joensuu et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Microscopically Positive Margins for Primary Gastrointestinal Stromal Tumors: Analysis of Risk Factors and Tumor Recurrence

(2012) Martin D. McCarter et al.   JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS

Validation of the Joensuu risk criteria for primary resectable gastrointestinal stromal tumour – The impact of tumour rupture on patient outcomes

(2011) P. Rutkowski et al.   EJSO

Risk of recurrence of gastrointestinal stromal tumour after surgery: an analysis of pooled population-based cohorts

(2011) Heikki Joensuu et al.   LANCET ONCOLOGY

Pattern of recurrence in patients with ruptured primary gastrointestinal stromal tumour

(2010) P. Hohenberger et al.   BRITISH JOURNAL OF SURGERY

Risk stratification of patients diagnosed with gastrointestinal stromal tumor

(2008) Heikki Joensuu   HUMAN PATHOLOGY

Tumor mitotic rate, size, and location independently predict recurrence after resection of primary gastrointestinal stromal tumor (GIST)

(2007) Ronald P. DeMatteo et al.   CANCER